Navigation Links
Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV™ (acetaminophen) injection for the Management of Pain and Fever
Date:11/2/2010

ch Equity Act (PREA) requirement included in the new drug application (NDA) approval for OFIRMEV, Cadence will conduct a post-marketing efficacy study of OFIRMEV in infants and neonates. The company expects to commence this study in 2011.  

Conference Call and Webcast Details

Cadence management will host a conference call on Tuesday, November 2, 2010 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time and interested investors may participate in the conference call by dialing (877) 303 – 9145 (domestic) or  (760) 536-5203 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website for thirty days through December 2, 2010.

About OFIRMEV™ (Acetaminophen) Injection

OFIRMEV (acetaminophen) injection is Cadence Pharmaceuticals' proprietary intravenous formulation of acetaminophen. OFIRMEV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.

For more information, please see the complete OFIRMEV Prescribing Information, available at http://www.Ofirmev.com or www.cadencepharm.com.

Important Safety Information:

OFIRMEV should be administered only as a 15 minute intravenous infusion. Do not exceed the maximum recommended daily dose of acetaminophen. Administration of acetaminophen by any route in doses higher than recommended may result in hepatic injury, including the risk of severe hepatotoxicity and death. OFIRMEV is contraindicated in patients with severe hepatic impairment, severe active liver disease or with known hypersensitivity to acetaminophen or to any of t
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
8. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
9. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
10. Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 Demanding industrial ... Lenses engineered of synthetic Sapphire and Glass Ball Lenses, ... from Swiss Jewel Company , of Philadelphia , ... expanding and collimating the light beams without the need ... clarity and natural durability (9 mohs) make it the ...
(Date:6/18/2013)... Nasseo, Inc. today announces that it has been ... of applicants by the Arizona Commerce Authority (ACA) ... The Arizona Innovation Challenge (AIC) awards the most money ... a financial award to what it deems to be ... the art dental and orthopedic implant surface modification technology ...
(Date:6/18/2013)... ATLANTA , June 18, 2013  regulated information ... Jeff Klauk today announced the launch of ... their loved ones. The Pledge ... take a stand and make a personal commitment to ... with their health care team and additional partial-onset seizure ...
(Date:6/18/2013)... DALLAS , June 18, 2013 ... Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) ... analyzes and studies the Major Market Drivers, Restraints, and Opportunities ... , Asia-Pacific and Rest of ... Data Tables 22 Figures ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3
... N.J., March 22, 2011 VENENUM Biodesign, a drug ... its compound collection to identify hits against its novel ... it will be exhibiting at the 17th SBS Annual ... Convention Center in Orlando, Florida, March 27-31, 2011. VENENUM ...
... sensor that opens up new ways to detect a ... to hidden explosives. The sensor, which is ... on a completely new architecture and fabrication technique developed ... generated by the scattering of laser light from a ...
... March 21, 2011 Coinstar, Inc. (Nasdaq: ... in SoloHealth, a consumer-driven healthcare technology company that ... including its award-winning EyeSite® product and the next-generation ... "As a leader in automated retail, ...
Cached Biology Technology:VENENUM Biodesign to Exhibit at SBS 2Princeton engineers make breakthrough in ultra-sensitive sensor technology 2Princeton engineers make breakthrough in ultra-sensitive sensor technology 3Coinstar to Invest in SoloHealth 2Coinstar to Invest in SoloHealth 3
(Date:6/18/2013)... , June 19, 2013  Paris Air ... as Geotest-Marvin Test Systems) , a leading provider ... aerospace industries, is demonstrating its solutions this week ... booth 3-C82. With growing challenges including increasingly complex ... demanding efficient, feature-rich, specialized aerospace test solutions that ...
(Date:6/18/2013)... Calgary,s Faculty of Medicine have discovered a mechanism that ... Platelets, a component of blood typically associated with clotting, ... upon detection, seal it off from the rest of ... Nature Immunology this week, provide the science community ... community has known that platelets do participate in immunity, ...
(Date:6/18/2013)... the United Kingdom, the Energy Department,s National Renewable ... have recently published a paper describing a novel ... Limnoria quadripunctata , commonly known as the gribble. ... exhibit a relatively unique ability to produce their ... break down the biomass they eat. New biomass-degrading ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2
... restriction in an environment that promotes overeating and inactivity ... This behavior may contribute to the increased risk ... hours, according to a research abstract that will be ... Meeting of the Associated Professional Sleep Societies (APSS). ...
... YORK (June 10, 2008) The Wildlife Conservation Society ... del Fuego to help protect the guanaco a ... herds from the Andean Plateau to the steppes of Patagonia., ... million animals that live in highly fragmented populations due to ...
... developed at The University of Texas at Austin that ... response has been used to create acellular nerve grafts ... also shows early promise of the detergent solution having ... solution combined with an enzyme treatment conceived at ...
Cached Biology News:Sleep restriction results in increased consumption of energy from snacks 2Study of guanacos launched in Chile 2Engineer develops detergent to promote peripheral nerve healing 2
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
A set of five peptides which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... Linkage: This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... C2C12 cells were cultured in DMEM and harvested ... order to keep the antigens in their native ... cells are arrayed on a 12-well (5 mm) ... treated to enhance cellular attachment and to minimize ...
Biology Products: